DJI45,960.11-1.01%
GDAXI22,612.97-1.50%
GSPC6,477.16-1.74%
HSI24,856.43-1.89%
IXIC21,408.08-2.38%
N22553,603.65-0.27%
AAPL252.89+0.11%
AMZN207.54-1.97%
CL93.79-0.73%
EURUSD1.1541-0.21%
GBPUSD1.3339-0.22%
GC4,376.90+0.01%
GOOG280.74-3.06%
JPM291.66-1.27%
META547.54-7.96%
MSFT365.97-1.37%
NVDA171.24-4.16%
TSLA372.11-3.59%
DJI45,960.11-1.01%
GDAXI22,612.97-1.50%
GSPC6,477.16-1.74%
HSI24,856.43-1.89%
IXIC21,408.08-2.38%
N22553,603.65-0.27%
AAPL252.89+0.11%
AMZN207.54-1.97%
CL93.79-0.73%
EURUSD1.1541-0.21%
GBPUSD1.3339-0.22%
GC4,376.90+0.01%
GOOG280.74-3.06%
JPM291.66-1.27%
META547.54-7.96%
MSFT365.97-1.37%
NVDA171.24-4.16%
TSLA372.11-3.59%
DJI45,960.11-1.01%
GDAXI22,612.97-1.50%
GSPC6,477.16-1.74%
HSI24,856.43-1.89%
IXIC21,408.08-2.38%
N22553,603.65-0.27%
AAPL252.89+0.11%
AMZN207.54-1.97%
CL93.79-0.73%
EURUSD1.1541-0.21%
GBPUSD1.3339-0.22%
GC4,376.90+0.01%
GOOG280.74-3.06%
JPM291.66-1.27%
META547.54-7.96%
MSFT365.97-1.37%
NVDA171.24-4.16%
TSLA372.11-3.59%
CYBERETIKAGLOBAL FINANCIAL INTELLIGENCE
LIVE
USA Seeking Alpha EN

CV Sciences Non-GAAP EPS of $0.00, revenue of $13.79M

Mar 26, 2026 &03042626202631; 20:04 UTC seekingalpha.com Trending 3/5
Read original on seekingalpha.com ↗
↘
Negative for markets
Sentiment score: -35/100
Moderate impact Short-term (days)
WHAT THIS MEANS
CV Sciences reported non-GAAP EPS of $0.00 with revenue of $13.79M—a break-even result that fails to demonstrate growth or profitability momentum. With the S&P 500 down 1.74% and VIX spiking 11.37%, risk-off sentiment dominates; a flat earnings result in a market selloff typically triggers further weakness in small-cap equities.
AI CONFIDENCE
62% High
SENTIMENT GAUGE
NEWS POWER SCORE
AFFECTED ASSETS
↓
CVSI
CVSIStock
Expected to decline
Break-even EPS ($0.00) with no earnings surprise; small-cap biotech/pharma typically underperforms in risk-off environments (VIX +11.37%, SPX -1.74%). Lack of positive catalyst combined with broad market weakness suggests 2-4% downside in 24h.
↓
S&P 500
^GSPCIndex
Expected to decline
S&P 500 already down 1.74% with elevated VIX (28.21); broad risk-off sentiment limits upside for small-cap equities like CVSI.
PRICE HISTORY
Loading chart...
⚡ SUGGESTED ACTION
CVSI lacks a positive catalyst to offset broad market weakness. Consider SHORT or AVOID; if holding, set stop-loss at -3% to protect against further downside in elevated-VIX environment. Monitor for guidance/commentary that might stabilize the stock. [MOVE:-2.5%]
KEY SIGNALS
Break-even non-GAAP EPS (no earnings beat)Revenue $13.79M (no growth context provided)VIX spike +11.37% (fear/risk-off)S&P 500 -1.74% (broad selloff)Small-cap vulnerability in market stress
SECTORS INVOLVED
HealthcareBiotechnology
Analysis generated on Mar 26, 2026 at 20:10 UTC
Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Seeking Alpha. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

RELATED INTELLIGENCE

RH appoints David Stanchak as chief real estate and transformation officer
Seeking Alpha Mar 26, 21:56 Neutral
Gold Lower on Mixed Signals Over Potential Iran Ceasefire
Bloomberg Markets Mar 26, 21:41 Neutral
QDRO Acquisition prices $200M IPO
Seeking Alpha Mar 26, 21:40 Neutral
Ryska oljeintäkter rusar – lappar ihop krigsekonomin
Dagens Industri Mar 26, 21:34 Negative
Mortgage Rates Jump to 6.38% as War Rattles Housing Market
Bloomberg Markets Mar 26, 21:30 Negative